DK1702623T3 - Anvendelse af interferon-gamma til behandling af hjertehypertrofi - Google Patents

Anvendelse af interferon-gamma til behandling af hjertehypertrofi

Info

Publication number
DK1702623T3
DK1702623T3 DK06013719T DK06013719T DK1702623T3 DK 1702623 T3 DK1702623 T3 DK 1702623T3 DK 06013719 T DK06013719 T DK 06013719T DK 06013719 T DK06013719 T DK 06013719T DK 1702623 T3 DK1702623 T3 DK 1702623T3
Authority
DK
Denmark
Prior art keywords
interferon
gamma
treatment
cardiac hypertrophy
hypertrophy
Prior art date
Application number
DK06013719T
Other languages
English (en)
Inventor
Hongkui Jin
Hsienwie Lu
Nicholas J Paoni
Renhui Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK1702623T3 publication Critical patent/DK1702623T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK06013719T 1998-04-02 1999-03-19 Anvendelse af interferon-gamma til behandling af hjertehypertrofi DK1702623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8044898P 1998-04-02 1998-04-02
PCT/US1999/006032 WO1999051260A2 (en) 1998-04-02 1999-03-19 Treatment of cardiac hypertrophy

Publications (1)

Publication Number Publication Date
DK1702623T3 true DK1702623T3 (da) 2009-01-19

Family

ID=22157456

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99912711T DK1067958T3 (da) 1998-04-02 1999-03-19 Behandling af hjertehypertrofi
DK06013719T DK1702623T3 (da) 1998-04-02 1999-03-19 Anvendelse af interferon-gamma til behandling af hjertehypertrofi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99912711T DK1067958T3 (da) 1998-04-02 1999-03-19 Behandling af hjertehypertrofi

Country Status (18)

Country Link
US (2) US6187304B1 (da)
EP (2) EP1702623B1 (da)
JP (2) JP5030329B2 (da)
CN (1) CN1201814C (da)
AR (1) AR018174A1 (da)
AT (2) ATE332144T1 (da)
AU (1) AU757910B2 (da)
BR (1) BR9909422A (da)
CA (1) CA2325442C (da)
DE (2) DE69932235T2 (da)
DK (2) DK1067958T3 (da)
ES (2) ES2314786T3 (da)
HK (2) HK1036019A1 (da)
IL (1) IL138812A0 (da)
NZ (1) NZ506854A (da)
TW (1) TWI243682B (da)
WO (1) WO1999051260A2 (da)
ZA (1) ZA200004854B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE69932235T2 (de) * 1998-04-02 2007-06-14 Genentech, Inc., South San Francisco Behandlung von herzhypertrophie
WO2001003720A2 (en) * 1999-07-12 2001-01-18 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
CA2466106A1 (en) * 2001-11-06 2003-05-15 Applied Research Systems Ars Holding N.V. Methods of treating endometreosis
US20050118163A1 (en) * 2002-02-14 2005-06-02 Hidefumi Mizushima Antibody-containing solution pharmaceuticals
ATE546143T1 (de) * 2002-08-29 2012-03-15 Santen Pharmaceutical Co Ltd Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen
US7972612B2 (en) * 2002-11-18 2011-07-05 Santen Pharmaceutical Co., Ltd. Remedy for glaucoma comprising Rho kinase inhibitor and β-blocker
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
WO2009154770A2 (en) * 2008-06-18 2009-12-23 The Texas A & M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US5582824A (en) 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US5096705A (en) 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US4929544A (en) 1982-04-23 1990-05-29 Sri International Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4944941A (en) 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
US5151265A (en) 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
SE462364B (sv) 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
CA2069870E (en) 1989-12-01 2005-01-11 Donald Y. M. Leung Treatment of atopic disorders with gamma-interferon
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
WO1997007820A1 (fr) * 1995-08-30 1997-03-06 Toray Industries, Inc. Remede destine aux maladies cardiaques
DE69932235T2 (de) * 1998-04-02 2007-06-14 Genentech, Inc., South San Francisco Behandlung von herzhypertrophie

Also Published As

Publication number Publication date
TWI243682B (en) 2005-11-21
ATE332144T1 (de) 2006-07-15
JP2002510645A (ja) 2002-04-09
NZ506854A (en) 2003-07-25
EP1702623A3 (en) 2007-01-10
US6989364B1 (en) 2006-01-24
HK1036019A1 (en) 2001-12-21
US6187304B1 (en) 2001-02-13
ES2314786T3 (es) 2009-03-16
ZA200004854B (en) 2001-09-26
CA2325442C (en) 2011-10-11
CA2325442A1 (en) 1999-10-14
WO1999051260A3 (en) 1999-12-09
CN1201814C (zh) 2005-05-18
CN1300221A (zh) 2001-06-20
DE69932235D1 (de) 2006-08-17
HK1099197A1 (en) 2007-08-10
ATE410181T1 (de) 2008-10-15
BR9909422A (pt) 2001-09-11
ES2267258T3 (es) 2007-03-01
EP1067958A2 (en) 2001-01-17
EP1702623B1 (en) 2008-10-08
WO1999051260A2 (en) 1999-10-14
JP5030329B2 (ja) 2012-09-19
AU757910B2 (en) 2003-03-13
DE69932235T2 (de) 2007-06-14
IL138812A0 (en) 2001-10-31
DE69939723D1 (de) 2008-11-20
EP1702623A2 (en) 2006-09-20
AR018174A1 (es) 2001-10-31
AU3102499A (en) 1999-10-25
DK1067958T3 (da) 2006-11-06
EP1067958B1 (en) 2006-07-05
JP2009256375A (ja) 2009-11-05

Similar Documents

Publication Publication Date Title
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DK0914103T3 (da) Behandling af hæmoglobinopati
ID25977A (id) Popok sekali pakai
ID24555A (id) Popok sekali pakai
ID23076A (id) Popok sekali pakai
DE60020817D1 (de) Planung von betriebsmitteln
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK0970386T3 (da) Impedans-til-spænding-konverter
ID29021A (id) Komposisi galantamina pelepasan terkontrol
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
DE69938817D1 (de) Erstellungsverfahren
DK1021194T3 (da) Ny forbedret formulering til behandling af osteoporose
FI20000863A (fi) Uusi hoitomenetelmä
FR2780269B1 (fr) Implant rachidien
ID28050A (id) Alat kesehatan
ID23083A (id) Popok sekali pakai
DE69934464D1 (de) Gleichstromwandler
NO20000904D0 (no) Borefartøy
DK1702623T3 (da) Anvendelse af interferon-gamma til behandling af hjertehypertrofi
DK199800837A (da) Anlæg til behandling af emner
PT1042414E (pt) Revestimentos anti-deposicao
DE59901977D1 (de) Analog-digital-umsetzer
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
ID30023A (id) Kombinasi senyawa aktif fungisida
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse